ACCELERATE

Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High Risk for Vascular Outcomes (HRVD) – the ACCELERATE Study

Stadium: klaar
Middel: evacetrapib
Populatie: ASCVD
Fase: III
First Patient In: 1 oktober 2012
Last Patient In: 1 september 2013
Last Patient Last Visit: -

Studiedirecteur

drs. B.J.B. Hamer

Cardioloog